Home › NCT07659158
Virtual Group Resilient Living Program For Patients Living With Advanced Cancer
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Inclusion Criteria: * English fluency * Diagnosis of advanced (stage III/IV) malignancy * Baseline distress score ≥ 4/10. Patients can answer questions orally rather than complete worksheet, if applicable * Life expectancy of ≥ 6 months * Provide informed consent * Ability to complete questionnaire(s) by themselves or with assistance * Has a reliable internet connection * Has the ability to utilize technology to watch online modules, \& participate in virtual sessions Exclusion Criteria: * As determined through self-report, those diagnosed with a history of a psychotic episode ≤ 5 years * All psychological co-morbidities such as a history of untreated schizophrenia, \& bipolar disease * A diagnosis of severe cognitive impairment
About the study
This study is a prospective, minimal risk, non-randomized, single-arm study to determine feasibility and assess effectiveness of a Virtual Group Resilient Living Program (RLP) on anxiety, stress, quality of life (QOL), coping, and fatigue among patients with advanced cancer. The group RLP is a psychosocial intervention that consists of a total of 7 weekly sessions in which the interventionalist teaches the patients techniques on stress management and building resilience (mindfulness, uplifting emotions, reframe experiences through principles of gratitude, compassion, acceptance, meaning, and forgiveness). The group setting allows for support and connection amongst the patients, providing further support and motivation to practice the principles of the program.
What is being tested
- Virtual Group Resilient Living Program (RLP) (behavioral)
- Survey Completion (other)
Sponsor: Mayo Clinic · Participants: 42 · Started: Jun 19, 2026
Contact the study team
- Clinical Trials Referral Office · Phone: 855-776-0015
Official record on ClinicalTrials.gov — NCT07659158
Locations in the U.S.
| Minnesota | Mayo Clinic in Rochester, Rochester |
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.